| Green tea extracts for the prevention of metachronous colorectal polyps among patients who underwent endoscopic removal of colorectal adenomas: A randomized clinical trial 2018 · supplementation group · Korean patients who had undergone endoscopic removal of colorectal adenomas; age and sex not specified | 900 mg | 1 year | 88 |
| Green tea extracts for the prevention of metachronous colorectal adenomas: a pilot study 2008 · GTE group · Patients with colorectal adenomas removed by endoscopic polypectomy, with a clean colon confirmed one year later | 1.5 g | 1 year | 71 |
| Effect of Catechins on Upper Respiratory Tract Infections in Winter: A Randomized, Placebo-Controlled, Double-Blinded Trial 2022 · catechin group · Healthy Japanese men and women aged 20–65 years | 490 mg | 12 weeks | 55 |
| Effect of green tea extract supplementation on exercise-induced delayed onset muscle soreness and muscular damage 2018 · green tea extract · Non-trained men; age not reported | 500 mg | 15 days | 10 |
| Does green tea extract enhance the anti-inflammatory effects of exercise on fat loss? 2020 · Endurance training + GTE (ET + GTE) · Inactive overweight women | 500 mg | 8 weeks | 10 |
| Green tea catechins improve human forearm endothelial dysfunction and have antiatherosclerotic effects in smokers 2010 · high-dose group · healthy male smokers | 580 mg | 2 weeks | — |
| The Impact of Decaffeinated Green Tea Extract on Fat Oxidation, Body Composition and Cardio-Metabolic Health in Overweight, Recreationally Active Individuals 2021 · dGTE · Adults over 18 who were recreationally active and overweight (BMI 25.0–29.9 kg/m² and/or body fat in the overweight category); healthy, without the listed cardio-metabolic or blood/liver disorders | 580 mg | 8 weeks | — |
| Effects of green tea catechins and theanine on preventing influenza infection among healthcare workers: a randomized controlled trial 2011 · catechin/theanine group · Healthcare workers older than 20 years; no diagnosed condition specified | 378 mg | 150 days | 97 |
| The impact of the catechol-O-methyltransferase genotype on vascular function and blood pressure after acute green tea ingestion 2012 · green tea extract · Adults with low-activity (AA) or high-activity (GG) COMT rs4680 genotypes; no health condition stated | 1.06 g | 1 day | 50 |
| Tea-induced improvement of endothelial function in humans: No role for epigallocatechin gallate (EGCG) 2017 · Green tea extract (GTE) · Healthy men aged 20–50 years without chronic disease or stated cardiovascular risk factors | 406 mg | 1 day | 50 |
| Effect of green tea on reward learning in healthy individuals: a randomized, double-blind, placebo-controlled pilot study 2013 · green tea · Healthy men and women aged 18–34 years | 1.2 g | 5 weeks | 24 |
| Effects of medium-term green tea extract supplementation combined with CrossFit workout on blood antioxidant status and serum brain-derived neurotrophic factor in young men: a pilot study 2019 · green tea extract (GTE) group · young adult men, physical education students, trained and participating in a six-week CrossFit program | 250 mg | 6 weeks | 8 |
| Effects of catechin enriched green tea on body composition 2010 · one serving of control drink and one serving of extra high-catechin GT1 · Moderately overweight Chinese subjects; age and sex not specified | 458 mg | 90 days | — |
| Effects of catechin enriched green tea on body composition 2010 · two servings of high-catechin GT2 · Moderately overweight Chinese subjects; age and sex not specified | 468 mg | 90 days | — |
| Therapeutic effect of high-dose green tea extract on weight reduction: A randomized, double-blind, placebo-controlled clinical trial 2016 · high-dose green tea group · Women with central obesity, BMI ≥27 kg/m² and waist circumference ≥80 cm | 857 mg | 12 weeks | — |
| A Randomized, Double-blind, Placebo-controlled Clinical Trial Examining the Effects of Green Tea Extract on Systemic Lupus Erythematosus Disease Activity and Quality of Life 2017 · intervention group · Adults with systemic lupus erythematosus; mean age 39.1 ± 10.3 years; sex not specified | 1 g | 12 weeks | — |
| Short-term Effects of Green Tea on Blood Pressure, Endothelial Function, and Metabolic Profile in Obese Prehypertensive Women: A Crossover Randomized Clinical Trial 2017 · Green tea extract (GTE) · Women with obesity and prehypertension; mean age 41.1 years | 500 mg | 4 weeks | 20 |
| Interaction effect of green tea consumption and resistance training on office and ambulatory cardiovascular parameters in women with high-normal/stage 1 hypertension 2021 · GT (green tea) · Women aged 35–55 with high-normal blood pressure to stage 1 essential hypertension | 500 mg | 9 weeks | 10 |
| Effects of Greenselect Phytosome® on weight maintenance after weight loss in obese women: a randomized placebo-controlled study 2016 · GSP group · Obese Caucasian women referred for a weight-loss lifestyle intervention; age range not stated | 300 mg | 90 days | 20 |
| Effectiveness of green tea mouthwash in postoperative pain control following surgical removal of impacted third molars: double blind randomized clinical trial 2013 · Green tea · Adults aged 18–30 with bilateral impacted mandibular third molars undergoing surgical removal | 30 mL | 7 days | 43 |
| Green tea extract decreases starch digestion and absorption from a test meal in humans: a randomized, placebo-controlled crossover study 2015 · Green tea extract (GTE) test · Healthy adults aged 19–26 years; 19 women and 9 men | 4 g | 1 day | 28 |
| Effect of green tea (Camellia sinensis) consumption on the components of metabolic syndrome in elderly 2012 · green tea group (GTG) · Adults aged 60 years or older with metabolic syndrome; elderly men and women | 3 g | 60 days | 24 |
| Tea catechin and caffeine activate brown adipose tissue and increase cold-induced thermogenic capacity in humans 2017 · single-ingestion catechin beverage (acute trial) · Healthy men; age range not reported; assessed for brown adipose tissue activity | 615 mg | 1 day | 15 |
| Tea catechin and caffeine activate brown adipose tissue and increase cold-induced thermogenic capacity in humans 2017 · catechin beverage twice daily (chronic trial) · Men with low brown adipose tissue activity; age range not reported | 1.23 g | 5 weeks | 10 |
| Protective effects of green tea extracts (polyphenon E and EGCG) on human cervical lesions 2003 · Poly E capsule · Patients with HPV-infected cervical lesions, including chronic cervicitis and mild, moderate or severe dysplasia; age and sex not specified | 200 mg | 12 weeks | 6 |
| Effects of catechin enriched green tea on body composition 2010 · two servings of extra high-catechin GT3 · Moderately overweight Chinese subjects; age and sex not specified | 886 mg | 90 days | — |
| Green tea catechins improve human forearm endothelial dysfunction and have antiatherosclerotic effects in smokers 2010 · medium-dose group · healthy male smokers | 80 mg | 2 weeks | — |
| Preliminary Clinical Evidence of the Antiplaque, Antigingivitis Efficacy of a Mouthwash Containing 2% Green Tea - A Randomised Clinical Trial 2015 · test group · Male subjects aged 18–60 with at least 20 sound natural teeth, plaque index of at least 1.5 and gingival index of at least 1.0 | 20 mL | 4 weeks | — |
| Comparative studies on the hypolipidemic, antioxidant and hepatoprotective activities of catechin-enriched green and oolong tea in a double-blind clinical trial 2018 · catechin-enriched green tea (CEGT) · Mildly hypercholesterolemic subjects | 781 mg | 12 weeks | — |
| Effects of green tea extract combined with brisk walking on lipid profiles and the liver function in overweight and obese men: A randomized, double-blinded, placebo-control trial 2020 · GTE group · Overweight and obese men | 300 mg | 12 weeks | — |
| The Effect of Dietary Supplements Containing Green Tea, Capsaicin and Ginger Extracts on Weight Loss and Metabolic Profiles in Overweight Women: A Randomized Double-Blind Placebo-Controlled Clinical Trial 2017 · Group A · Overweight women | 500 mg | 8 weeks | 25 |
| Protective effects of green tea extracts (polyphenon E and EGCG) on human cervical lesions 2003 · Poly E ointment plus Poly E capsule · Patients with HPV-infected cervical lesions, including chronic cervicitis and mild, moderate or severe dysplasia; age and sex not specified | 200 mg | 12 weeks | 8 |
| Double-blinded, placebo-controlled trial of green tea extracts in the clinical and histologic appearance of photoaging skin 2005 · green tea-treated group · Women with moderate photoaging | 600 mg | 8 weeks | — |
| Does supplementation with green tea extract improve acne in post-adolescent women? A randomized, double-blind, and placebo-controlled clinical trial 2016 · decaffeinated green tea extract group · Women aged 25–45 years with moderate-to-severe post-adolescent acne | 1.5 g | 4 weeks | — |
| The Impact of Decaffeinated Green Tea Extract on Fat Oxidation, Body Composition and Cardio-Metabolic Health in Overweight, Recreationally Active Individuals 2021 · dGTE+ · Adults over 18 who were recreationally active and overweight (BMI 25.0–29.9 kg/m² and/or body fat in the overweight category); healthy, without the listed cardio-metabolic or blood/liver disorders | 580 mg | 8 weeks | — |
| A multimodal lifestyle intervention complemented with epigallocatechin gallate to prevent cognitive decline in APOE- ɛ4 carriers with Subjective Cognitive Decline: a randomized, double-blinded clinical trial (PENSA study) 2025 · MLI+EGCG, participants weighing 50 kg or less · Adults aged 60–80 with subjective cognitive decline who carried APOE-ε4 and had normal-range cognitive performance | 677 mg | 1 year | — |
| A multimodal lifestyle intervention complemented with epigallocatechin gallate to prevent cognitive decline in APOE- ɛ4 carriers with Subjective Cognitive Decline: a randomized, double-blinded clinical trial (PENSA study) 2025 · MLI+EGCG, participants weighing more than 50 kg · Adults aged 60–80 with subjective cognitive decline who carried APOE-ε4 and had normal-range cognitive performance | 1.13 g | 1 year | — |
| Green tea extract supplementation gives protection against exercise-induced oxidative damage in healthy men 2011 · GTE · Previously untrained male students; age and health conditions beyond being previously untrained are not specified | 640 mg | 4 weeks | 17 |
| Prospective randomized trial evaluating blood and prostate tissue concentrations of green tea polyphenols and quercetin in men with prostate cancer 2020 · GT + placebo · Men aged 43–74 with clinically localized prostate adenocarcinoma scheduled for radical prostatectomy | 500 mg | 4 weeks | 16 |
| Acute Ingestion of a Mixed Flavonoid and Caffeine Supplement Increases Energy Expenditure and Fat Oxidation in Adult Women: A Randomized, Crossover Clinical Trial 2019 · Mixed flavonoid-caffeine (MFC) supplement · Healthy premenopausal women aged 20–47 years | 368 mg | 1 day | 19 |
| Acute effectiveness of a "fat-loss" product on substrate utilization, perception of hunger, mood state and rate of perceived exertion at rest and during exercise 2015 · SHRED · Healthy recreationally active adults, 24 ± 3.8 years old; five women and seven men | 70 mg | 1 day | 12 |
| A Combination of Essential Fatty Acids, Panax Ginseng Extract, and Green Tea Catechins Modifies Brain fMRI Signals in Healthy Older Adults 2018 · Investigational product (Cerbella) · Adults aged 55–75 years who were cognitively healthy and non-demented | 26 mg | 26 days | 10 |
| A green tea extract high in catechins reduces body fat and cardiovascular risks in humans 2007 · catechin group · Japanese women and men with visceral fat-type obesity; age range not reported | 583 mg | 12 weeks | 123 |
| "Benifuuki" Extract Reduces Serum Levels of Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 Ligands Containing Apolipoprotein B: A Double-Blind Placebo-Controlled Randomized Trial 2018 · Group H, high-dose “Benifuuki” extract · Healthy Japanese adults aged 23–80 with serum LDL cholesterol above 3.10 mmol/L and BMI above 18.5 kg/m² | 676 mg | 12 weeks | 53 |
| The Effect of Green Tea and Sour Tea (Hibiscus sabdariffa L.) Supplementation on Oxidative Stress and Muscle Damage in Athletes 2017 · green tea extract group · Male soccer players | 450 mg | 6 weeks | 18 |
| Daily consumption of an aqueous green tea extract supplement does not impair liver function or alter cardiovascular disease risk biomarkers in healthy men 2009 · green tea extract treatment · Healthy men; ages 41 ± 9 years on average; no age range reported. | 714 mg | 3 weeks | 17 |
| Effects of green tea extract supplementation and endurance training on irisin, pro-inflammatory cytokines, and adiponectin concentrations in overweight middle-aged men 2020 · endurance training + green tea extract supplementation (ET + GTE) · Overweight middle-aged men | 500 mg | 8 weeks | 15 |
| Effects of Green Tea Extract on Atorvastatin Pharmacokinetics in Healthy Volunteers 2020 · atorvastatin 40 mg plus 600 mg green tea extract · 12 healthy volunteers; age and sex not reported | 600 mg | 1 day | 12 |
| Randomized controlled trial for an effect of green tea-extract powder supplementation on glucose abnormalities 2008 · Early intervention group · Adults aged 32–73 years with elevated fasting or nonfasting blood glucose | 544 mg | 60 days | — |
| Randomized controlled trial for an effect of green tea-extract powder supplementation on glucose abnormalities 2008 · Later intervention group · Adults aged 32–73 years with elevated fasting or nonfasting blood glucose | 544 mg | 60 days | — |
| The effect of caffeine, green tea and tyrosine on thermogenesis and energy intake 2009 · green tea extract (GTE) · healthy, normal-weight men, mean age 23.7 years | 500 mg | 1 day | — |
| Effect of endurance training supplemented with green tea extract on substrate metabolism during exercise in humans 2011 · GTE group · Healthy male subjects; age not reported | 573 mg | 10 weeks | — |
| Effects of a green tea extract, Polyphenon E, on systemic biomarkers of growth factor signalling in women with hormone receptor-negative breast cancer 2015 · Poly E 400 mg EGCG twice daily · Women aged 21–65 with a history of resected stage I–III hormone receptor-negative breast cancer, without evidence of disease | 800 mg | 26 weeks | 16 |
| Effects of a green tea extract, Polyphenon E, on systemic biomarkers of growth factor signalling in women with hormone receptor-negative breast cancer 2015 · Poly E 600 mg EGCG twice daily · Women aged 21–65 with a history of resected stage I–III hormone receptor-negative breast cancer, without evidence of disease | 1.2 g | 26 weeks | 11 |
| Effect of acute administration of an herbal preparation on blood pressure and heart rate in humans 2011 · Experimental treatment product (Acceleron®) · Mildly overweight adult men and women; ages not stated | 222 mg | 1 day | 23 |
| Green Tea Catechin Extract Supplementation Does Not Influence Circulating Sex Hormones and Insulin-Like Growth Factor Axis Proteins in a Randomized Controlled Trial of Postmenopausal Women at High Risk of Breast Cancer 2019 · GTE group · Healthy postmenopausal women; mean age 60.0 years; at high risk of breast cancer | 1.32 g | 1 year | 538 |
| Hepatotoxicity with High-Dose Green Tea Extract: Effect of Catechol-O-Methyltransferase and Uridine 5'-Diphospho-glucuronosyltransferase 1A4 Genotypes 2023 · GTE treatment group · Postmenopausal women aged 50–70 with high mammographic density; healthy, with BMI 18.5–40 and baseline alcohol consumption no more than 14 g ethanol per day for this secondary analysis | 843 mg | 1 year | 400 |
| Green Tea Extract and Catechol-O-Methyltransferase Genotype Modify Fasting Serum Insulin and Plasma Adiponectin Concentrations in a Randomized Controlled Trial of Overweight and Obese Postmenopausal Women 2016 · Decaffeinated green tea extract (GTE) · Overweight or obese healthy postmenopausal women (BMI ≥25 kg/m²); age range not stated | 1.32 g | 1 year | 117 |
| "Benifuuki" Extract Reduces Serum Levels of Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 Ligands Containing Apolipoprotein B: A Double-Blind Placebo-Controlled Randomized Trial 2018 · Group L, low-dose “Benifuuki” extract · Healthy Japanese adults aged 23–80 with serum LDL cholesterol above 3.10 mmol/L and BMI above 18.5 kg/m² | 322 mg | 12 weeks | 53 |
| A green tea extract confection decreases circulating endotoxin and fasting glucose by improving gut barrier function but without affecting systemic inflammation: A double-blind, placebo-controlled randomized trial in healthy adults and adults with metabolic syndrome 2024 · Green tea extract confection · Healthy adults aged 34 ± 2 years and adults with metabolic syndrome aged 40 ± 3 years | 890 mg | 4 weeks | 40 |
| Mitigation of oxidative damage by green tea polyphenols and Tai Chi exercise in postmenopausal women with osteopenia 2012 · GTP group · Postmenopausal women with osteopenia; mean age 56.5 years (SD 5.5) | 500 mg | 26 weeks | 39 |
| Effects of green tea extract on insulin resistance and glucagon-like peptide 1 in patients with type 2 diabetes and lipid abnormalities: a randomized, double-blinded, and placebo-controlled trial 2014 · Decaffeinated EGCG (Group A) · Adults aged 20–65 with type 2 diabetes for more than one year and elevated triglycerides or LDL cholesterol | 1.5 g | 16 weeks | 39 |
| Effect of 2-month controlled green tea intervention on lipoprotein cholesterol, glucose, and hormone levels in healthy postmenopausal women 2012 · 400 mg EGCG as PPE group · Postmenopausal women aged 45 years or older, not using menopausal hormone therapy; healthy, non-regular tea drinkers | 400 mg | 60 days | 37 |
| Mitigation of oxidative damage by green tea polyphenols and Tai Chi exercise in postmenopausal women with osteopenia 2012 · GTP+TC group · Postmenopausal women with osteopenia; mean age 57.6 years (SD 6.7) | 500 mg | 26 weeks | 37 |
| Effect of 2-month controlled green tea intervention on lipoprotein cholesterol, glucose, and hormone levels in healthy postmenopausal women 2012 · 800 mg EGCG as PPE group · Postmenopausal women aged 45 years or older, not using menopausal hormone therapy; healthy, non-regular tea drinkers | 800 mg | 60 days | 34 |
| Green tea extract outperforms metformin in lipid profile and glycaemic control in overweight women: A double-blind, placebo-controlled, randomized trial 2017 · green tea · Overweight, non-diabetic women | 1 g | 12 weeks | 32 |
| Green tea extract outperforms metformin in lipid profile and glycaemic control in overweight women: A double-blind, placebo-controlled, randomized trial 2017 · green tea + metformin · Overweight, non-diabetic women | 1 g | 12 weeks | 31 |
| The effect of green tea extract supplementation on exercise-induced oxidative stress parameters in male sprinters 2015 · GTE · Male sprinters aged 21.6 ± 1.5 years, participating in a university sports club | 1 g | 4 weeks | 16 |
| A 60-Day Green Tea Extract Supplementation Counteracts the Dysfunction of Adipose Tissue in Overweight Post-Menopausal and Class I Obese Women 2022 · GSP (supplemented) group · Overweight or class I obese sedentary post-menopausal women; mean age 58.75 years | 300 mg | 60 days | 14 |
| Effects of Green Tea Extract on Atorvastatin Pharmacokinetics in Healthy Volunteers 2020 · atorvastatin 40 mg plus 300 mg green tea extract · 12 healthy volunteers; age and sex not reported | 300 mg | 1 day | 12 |
| Supplementation with Brazil nuts and green tea extract regulates targeted biomarkers related to colorectal cancer risk in humans 2016 · Green tea extract · Volunteers over 50 years of age with plasma selenium ≤1.36 µmol/L | 800 mg | — | 11 |
| Polyphenon E, non-futile at neuroprotection in multiple sclerosis but unpredictably hepatotoxic: Phase I single group and phase II randomized placebo-controlled studies 2015 · PhI Polyphenon E · Adults aged 18–60 with relapsing-remitting or secondary progressive multiple sclerosis | 400 mg | 26 weeks | 10 |
| Exposure of Fexofenadine, but Not Pseudoephedrine, Is Markedly Decreased by Green Tea Extract in Healthy Volunteers 2022 · GTE phase · Healthy Japanese volunteers aged 21–45 years, 8 men and 2 women | 325 mg | 1 day | 10 |
| Polyphenon E, non-futile at neuroprotection in multiple sclerosis but unpredictably hepatotoxic: Phase I single group and phase II randomized placebo-controlled studies 2015 · PhII Polyphenon E · Adults aged 18–60 with relapsing-remitting or secondary progressive multiple sclerosis | 400 mg | 1 year | 6 |
| Cholesterol-lowering effect of a theaflavin-enriched green tea extract: a randomized controlled trial 2003 · theaflavin-enriched green tea extract group · Men and women aged 18 years or older with mild to moderate hypercholesterolemia, on a low-fat diet | 375 mg | 12 weeks | — |
| Green tea extract reduces blood pressure, inflammatory biomarkers, and oxidative stress and improves parameters associated with insulin resistance in obese, hypertensive patients 2012 · green tea extract group · obese, hypertensive patients; age and sex not specified | 379 mg | 90 days | — |
| Effect of green tea extract on arterial stiffness, lipid profile and sRAGE in patients with type 2 diabetes mellitus: a randomised, double-blind, placebo-controlled trial 2019 · green tea extract · Adults with type 2 diabetes mellitus; mean age 53.2 years | 400 mg | 12 weeks | — |
| Green Tea Extract Increases Soluble RAGE and Improves Renal Function in Patients with Diabetic Nephropathy 2021 · GTE group · Patients with type 2 diabetes mellitus and diabetic nephropathy; age and sex not reported | 800 mg | 90 days | — |
| The influence of green tea extract on nintedanib's bioavailability in patients with pulmonary fibrosis 2022 · Period B: nintedanib with green tea extract · Patients with pulmonary fibrosis | 1 g | 7 days | — |
| Prospective randomized trial evaluating blood and prostate tissue concentrations of green tea polyphenols and quercetin in men with prostate cancer 2020 · GT + Q · Men aged 43–74 with clinically localized prostate adenocarcinoma scheduled for radical prostatectomy | 500 mg | 4 weeks | 15 |
| Effects of a green tea extract, Polyphenon E, on systemic biomarkers of growth factor signalling in women with hormone receptor-negative breast cancer 2015 · Poly E 800 mg EGCG twice daily · Women aged 21–65 with a history of resected stage I–III hormone receptor-negative breast cancer, without evidence of disease | 1.6 g | 26 weeks | 3 |
| Influence of green and black tea on folic acid pharmacokinetics in healthy volunteers: potential risk of diminished folic acid bioavailability 2008 · 0.4 mg folic acid with green tea · Healthy volunteers; age and sex not specified | 300 mg | 1 day | — |
| Effect of green tea extract (catechins) in reducing oxidative stress seen in patients of pulmonary tuberculosis on DOTS Cat I regimen 2010 · catechin · Newly diagnosed adults with AFB-positive pulmonary tuberculosis receiving CAT I antitubercular treatment; age and sex not reported | 500 mcg | 120 days | 100 |
| Effect of yerba mate and green tea on paraoxonase and leptin levels in patients affected by overweight or obesity and dyslipidemia: a randomized clinical trial 2019 · green tea group · Men and women aged 35–60 with overweight or obesity and dyslipidemia, without prior cardiovascular disease | 5 g | 8 weeks | 49 |
| Green tea polyphenols supplementation and Tai Chi exercise for postmenopausal osteopenic women: safety and quality of life report 2010 · GTP group · Postmenopausal women with osteopenia; at least 2 years after menopause | 500 mg | 24 weeks | 47 |
| Redox-linked effects of green tea on DNA damage and repair, and influence of microsatellite polymorphism in HMOX-1: results of a human intervention trial 2015 · Green tea · Adults with type 2 diabetes; 20 with short and 23 with long HMOX-1 promoter GT repeats | 300 mL | 12 weeks | 43 |
| Green tea polyphenols supplementation and Tai Chi exercise for postmenopausal osteopenic women: safety and quality of life report 2010 · GTP + TC group · Postmenopausal women with osteopenia; at least 2 years after menopause | 500 mg | 24 weeks | 38 |
| Antimicrobial properties of green tea extract against cariogenic microflora: an in vivo study 2011 · Group A · Healthy people aged 12–18 years | 120 mL | 7 days | 33 |
| Simultaneous ingestion of dietary proteins reduces the bioavailability of galloylated catechins from green tea in humans 2013 · GT (control) · Healthy normal-weight women | 1.75 g | 1 day | 24 |
| Green tea extract only affects markers of oxidative status postprandially: lasting antioxidant effect of flavonoid-free diet 2002 · Green tea extract intervention · Eight smokers and eight non-smokers | 18.6 mg | 3 weeks | 16 |
| Metabolic response to green tea extract during rest and moderate-intensity exercise 2013 · GTE · Healthy, physically active males | 1.2 g | 7 days | 13 |
| Green Tea Extract Concurrent with an Oral Nutritional Supplement Acutely Enhances Muscle Microvascular Blood Flow without Altering Leg Glucose Uptake in Healthy Older Adults 2021 · GTE condition · Healthy men and women aged 65 years or older, without active metabolic disease | 300 mg | 1 day | 12 |
| Effects of green tea extract on serum uric acid and urate clearance in healthy individuals 2014 · GTE2 · Healthy individuals; age and sex not reported | 2 g | 2 weeks | 11 |
| Effects of green tea extract on serum uric acid and urate clearance in healthy individuals 2014 · GTE4 · Healthy individuals; age and sex not reported | 4 g | 2 weeks | 11 |
| Effects of green tea extract on serum uric acid and urate clearance in healthy individuals 2014 · GTE6 · Healthy individuals; age and sex not reported | 6 g | 2 weeks | 8 |
| Effect of green tea and Tai Chi on bone health in postmenopausal osteopenic women: a 6-month randomized placebo-controlled trial 2012 · GTP · Postmenopausal women with osteopenia | 500 mg | 26 weeks | — |
| Effect of green tea and Tai Chi on bone health in postmenopausal osteopenic women: a 6-month randomized placebo-controlled trial 2012 · GTP + TC · Postmenopausal women with osteopenia | 500 mg | 26 weeks | — |
| Green tea with high-density catechins improves liver function and fat infiltration in non-alcoholic fatty liver disease (NAFLD) patients: a double-blind placebo-controlled study 2013 · high-density catechin group · Patients with non-alcoholic fatty liver disease (NAFLD); age and sex not specified | 700 mL | 12 weeks | — |
| Effects of green tea supplementation on elements, total antioxidants, lipids, and glucose values in the serum of obese patients 2012 · GTE group · Adults aged 30–60 with obesity (BMI ≥30 kg/m²), 23 men and 23 women across the study | 379 mg | 90 days | 23 |
| Supplementation with Brazil nuts and green tea extract regulates targeted biomarkers related to colorectal cancer risk in humans 2016 · Combination of Brazil nuts and green tea extract · Volunteers over 50 years of age with plasma selenium ≤1.36 µmol/L | 800 mg | — | 12 |
| Evaluating the Effect of Epigallocatechin Gallate (EGCG) in Reducing Folate Levels in Reproductive Aged Women by MTHFR and DHFR Genotype in Combination With Letrozole or Clomiphene 2025 · EGCG · Non-pregnant, non-lactating women aged 18–40 years, with or without uterine fibroids | 1.6 g | 30 days | 12 |
| Evaluating the Effect of Epigallocatechin Gallate (EGCG) in Reducing Folate Levels in Reproductive Aged Women by MTHFR and DHFR Genotype in Combination With Letrozole or Clomiphene 2025 · EGCG + letrozole · Non-pregnant, non-lactating women aged 18–40 years, with or without uterine fibroids | 1.6 g | 30 days | 10 |
| Evaluating the Effect of Epigallocatechin Gallate (EGCG) in Reducing Folate Levels in Reproductive Aged Women by MTHFR and DHFR Genotype in Combination With Letrozole or Clomiphene 2025 · EGCG + clomiphene · Non-pregnant, non-lactating women aged 18–40 years, with or without uterine fibroids | 1.6 g | 30 days | 8 |
| Influence of green and black tea on folic acid pharmacokinetics in healthy volunteers: potential risk of diminished folic acid bioavailability 2008 · 5 mg folic acid with green tea · Healthy volunteers; age and sex not specified | 300 mg | 1 day | — |
| Personalized Cardio-Metabolic Responses to an Anti-Inflammatory Nutrition Intervention in Obese Adolescents: A Randomized Controlled Crossover Trial 2018 · Anti-inflammatory nutrition supplement (AINS) · Overweight and obese adolescents aged 13–18 years | 416 mg | 8 weeks | 70 |
| The safety of green tea extract supplementation in postmenopausal women at risk for breast cancer: results of the Minnesota Green Tea Trial 2015 · GTE · Postmenopausal women aged 50–70 years with high mammographic density and no history of cancer or proliferative breast disease | 1.32 g | 1 year | 538 |
| Green tea extract and catechol-O-methyltransferase genotype modify the post-prandial serum insulin response in a randomised trial of overweight and obese post-menopausal women 2017 · GTE · Postmenopausal women aged 50–70 years who were overweight or obese and had dense breast tissue | 1.32 g | 1 year | 30 |
| Supplementation with lutein or lutein plus green tea extracts does not change oxidative stress in adequately nourished older adults 2010 · lutein plus green tea extract group · Men and postmenopausal women aged 50–70 years in good health | 200 mg | 16 weeks | 20 |
| Impact of Green Tea Catechin Ingestion on the Pharmacokinetics of Lisinopril in Healthy Volunteers 2021 · GTE phase · Healthy Japanese adults aged 21–29 years; 7 men and 5 women enrolled | 325 mg | 1 day | 10 |
| Green tea minimally affects biomarkers of inflammation in obese subjects with metabolic syndrome 2011 · green tea extracts · Adults with obesity and metabolic syndrome; age and sex not further specified | 1 g | 8 weeks | — |
| Simultaneous ingestion of dietary proteins reduces the bioavailability of galloylated catechins from green tea in humans 2013 · GT + M · Healthy normal-weight women | 1.75 g | 1 day | — |
| Simultaneous ingestion of dietary proteins reduces the bioavailability of galloylated catechins from green tea in humans 2013 · GT + CS · Healthy normal-weight women | 1.75 g | 1 day | — |
| Simultaneous ingestion of dietary proteins reduces the bioavailability of galloylated catechins from green tea in humans 2013 · GT + S · Healthy normal-weight women | 1.75 g | 1 day | — |
| A Mixed Flavonoid-Fish Oil Supplement Induces Immune-Enhancing and Anti-Inflammatory Transcriptomic Changes in Adult Obese and Overweight Women-A Randomized Controlled Trial 2016 · Q-Mix · Women aged 40–70 years who were overweight or obese (BMI ≥25 kg/m²), without the listed major diseases | 60 mg | 10 weeks | 24 |
| Effects of catechin enriched green tea on body composition 2010 · two servings of control drink (C) · Moderately overweight Chinese subjects; age and sex not specified | 30 mg | 90 days | — |